Lonza Group AG — Cyborg Score 8/10

Strong
Contract Development and Manufacturing Organization (CDMO) / Pharmaceutical Manufacturing Services

Strategic Profile

Lonza's business model has proven resilient, effectively diversifying risks across the broadest technology offering, commercial portfolio and global manufacturing footprint in the CDMO industry. The strong economic rationale to outsource to CDMOs remains unchanged for large pharma and biotech companies to enable economically efficient global pharmaceutical supply.

Cyborg Score Rationale

Lonza reported strong 2025 revenue growth of 17.3% (constant exchange rate), beating consensus, with core EBITDA margin of 30.6% outperforming expectations. For 2026, the company forecast 11-12% constant exchange rate sales growth and core EBITDA margin exceeding 32%, above consensus.

Top Insights

  • Integrated Biologics reported strong constant exchange rate sales growth of 32.2% in 2025, driven by sustained demand across large-, mid-, and small-scale assets.
  • Capital expenditure is expected to normalize to 17-19% of sales in 2026 as the investment peak passes.
  • Lonza achieved 50%+ reductions in GHG and waste intensity, surpassing 2030 targets ahead of schedule, with all electricity in key regions now from renewable sources as of January 2026.
  • The Capsules and Health Ingredients business is classified as discontinued operations with exit process advancing as planned.

Named Competitors

  • Siegfried Holding — Swiss CDMO competitor
  • Patheon — Integrated CDMO services
  • CordenPharma — Contract manufacturer of small molecules
  • Vetter Pharma — Fill-finish and CDMO provider

Recent Developments

  • (January 2026) Lonza delivered strong 2025 results with CHF 7.62B revenue and 30.6% core EBITDA margin; forecasted 11-12% growth for 2026
  • (January 2026) All electricity purchased across US, Europe and China now sourced from renewable energy
  • (October 2025) Claudia Süssmuth-Dyckerhoff nominated as Independent Member and Vice-Chair of Board of Directors

Open the full interactive Lonza Group AG report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →